Vitadieu (Cholecalciferol)

Adult administration

Administer 200,000 IU of cholecalciferol via intramuscular injection. Elderly patients should receive 100,000 IU of cholecalciferol via intramuscular injection. Ensure that the annual total does not exceed 600,000 IU of cholecalciferol.

Child administration

Administer 200,000 IU of cholecalciferol via intramuscular injection.

This medication contains vitamin D, so overdosing should be avoided. When using with vitamin D fortified foods or other vitamin D preparations, total vitamin D intake should be verified. Blood calcium levels should be monitored periodically to ensure they do not exceed normal ranges, especially if serum calcium is above 10.5 mg/dL or urinary calcium exceeds certain criteria, use should be discontinued. In cases of high calcium intake, it is important to regularly observe calcium levels in the blood and urine. Individuals with allergies to any component of this drug, hypercalcemia, calcium stones, or kidney disorders should not use it. Additionally, immobile patients, patients with specific diseases, and women who are pregnant or breastfeeding should also refrain from using this medicine. During use, various side effects may occur such as headache, fatigue, muscle pain, digestive disturbances, thirst, increased urine output, elevated blood pressure, and kidney issues; if any abnormal symptoms occur, medical consultation should be sought immediately. In particular, blood levels of vitamin D and parathyroid hormone should be monitored periodically to prevent side effects from overdose. Those with reduced kidney function, elderly patients, or those taking certain diuretics or cardiac medications must undergo regular kidney function tests and may require dose adjustments. This drug may interact with other medications; therefore, if taking anticonvulsants, steroids, certain diuretics, antacids, or anticoagulants, medical personnel should be informed. It is advisable not to use this medication during pregnancy as overdose can harm the fetus. Its safety and efficacy have not been established for children under the age of 12, hence it should not be used in this age group. In case of overdose, this drug should be stopped immediately, calcium intake should be reduced, and hydration should be increased while diuresis-promoting treatment may be necessary. This medication should not be mixed with other medications, should be used quickly after opening, and any remaining drug should be discarded. Store this drug in a sealed container that prevents light exposure at room temperature between 1 and 30 degrees Celsius. Storing it this way will keep its components stable and safe for use.

Serious side effects

• Arrhythmia
• kidney issues
• hypercalcemia
• calcium stones
• urticaria

Mild side effects

• Headache
• weakness
• fatigue
• muscle pain
• loss of appetite
• weight loss
• stunted growth
• nausea
• vomiting
• constipation

This drug should be stored in a sealed container that blocks light, preferably at room temperature between 1 and 30 degrees Celsius. This storage method ensures the components of the drug remain unchanged and safe for usage.

Appearance

A clear, pale yellow solution contained in a brown glass ampoule

Package unit

5 ampoules/box [1mL/ampoule × 5 ampoules], 10 ampoules/box [1mL/ampoule × 10 ampoules]